Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block

Heart Rhythm

Volumn 12, Issue 12, 2015, Pages 2477-2485

  Orii, Makoto ^a   Hirata, Kumiko ^a   Tanimoto, Takashi ^a   Ota, Shingo ^a   Shiono, Yasutsugu ^a   Yamano, Takashi ^a   Matsuo, Yoshiki ^a   Ino, Yasushi ^a   Yamaguchi, Tomoyuki ^a   Kubo, Takashi ^a   Tanaka, Atsushi ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

18F fluoro 2 deoxyglucose positron emission tomography; Cardiac sarcoidosis; Complete heart block; Inflammation; Magnetic resonance imaging

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; CORONARY RISK; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; MYOCARDITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; THERAPY EFFECT; TREATMENT RESPONSE; CARDIOMYOPATHIES; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; HEART BLOCK; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGED; CARDIOMYOPATHIES; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEART BLOCK; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 84959865044     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.06.032     Document Type: Article

References (33)

1. D.R. Moller Cells and cytokines involved in the pathogenesis of sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 16 1999 24 31
2. W.C. Roberts, H.A. McAllister Jr, and V.J. Ferrans Sarcoidosis of the heart: a clinicopathological study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group II) Am J Med 63 1977 86 108
3. N. Takeda, I. Yokoyama, Y. Hiroi, M. Sakata, T. Harada, F. Nakamura, Y. Murakawa, and R. Nagai Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis Circulation 105 2002 1144 1145
4. R. Kandolin, J. Lehtonen, and M. Kupari Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults Circ Arrhythm Electrophysiol 4 2011 303 309
5. M.R. Patel, P.J. Cawley, J.F. Heitner, I. Klem, M.A. Parker, W.A. Jaroudi, T.J. Meine, J.B. White, M.D. Elliott, H.W. Kim, R.M. Judd, and R.J. Kim Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
6. J.P. Smedema, G. Snoep, M.P. van Kroonenburgh, R.J. van Geuns, W.R. Dassen, A.P. Gorgels, and H.J. Crijns Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690
7. B.A. Mc Ardle, E. Leung, H. Ohira, M.S. Cocker, R.A. deKemp, J. DaSilva, D. Birnie, R.S. Beanlands, and P.B. Nery The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis J Nucl Cardiol 20 2013 297 306
8. 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2012 241 248
9. R. Blankstein, M. Osborne, M. Naya, and et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis J Am Coll Cardiol 63 2014 329 336
10. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 2008 933 941
11. D. Mehta, S.A. Lubitz, Z. Frankel, J.P. Wisnivesky, A.J. Einstein, M. Goldman, J. Machac, and A. Teirstein Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing Chest 133 2008 1426 1435
12. D.H. Birnie, W.H. Sauer, F. Bogun, and et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis Heart Rhythm 11 2014 1305 1323
13. H. Hiraga, K. Yuwa, and M. Hiroe Guideline for the diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease [in Japanese] Tokyo, Japan: Japanese Ministry of Health and Welfare 1993 23 24
14. Diagnostic standard and guidelines for sarcoidosis [in Japanese] Jpn J Sarcoidosis Granulomatous Disord 27 2007 89 102
15. K. Soejima, and H. Yada The work-up and management of patients with apparent or subclinical cardiac sarcoidosis, with emphasis on the associated heart rhythm abnormalities J Cardiovasc Electrophysiol 20 2009 578 583
16. B.P. Betensky, C.M. Tschabrunn, E.S. Zado, L.R. Goldberg, F.E. Marchlinski, F.C. Garcia, and J.M. Cooper Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators Heart Rhythm 9 2012 884 891
17. 18F-fluorodoexyglucose positron emission tomography? Circ Cardiovasc Imaging 6 2013 617 626
18. J. Machac, S.L. Bacharach, T.M. Bateman, and et al. for the Quality Assurance Committee of the American Society of Nuclear Cardiology. Positron emission tomography myocardial perfusion and glucose metabolism imaging J Nucl Cardiol 13 2006 e121 e151
19. 18F-FDG: standardized uptake values in normal tissues J Nucl Med 45 2004 784 788
20. 18F-fluorodeoxyglucose positron emission tomography: an autopsy case [published correction appears in Circulation 2010;122:e464] Circulation 122 2010 535 536
21. T. Tanimoto, T. Imanishi, H. Kitabata, and et al. Prevalence and clinical significance of papillary muscle infarction detected by late gadolinium-enhanced magnetic resonance imaging in patients with ST-segment elevation myocardial infarction Circulation 122 2010 2281 2287
22. O. Bondarenko, A.M. Beek, M.B. Hofman, H.P. Kühl, J.W. Twisk, W.G. van Dockum, C.A. Visser, and A.C. van Rossum Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR J Cardiovasc Magn Reson 7 2005 481 485
23. J.S. Kim, M.A. Judson, R. Donnino, M. Gold, L.T. Cooper Jr, E.N. Prystowsky, and S. Prystowsky Cardiac sarcoidosis Am Heart J 157 2009 9 21
24. 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis Eur J Nucl Med Mol Imaging 40 2013 1558 1566
25. F. Tavora, N. Cresswell, L. Li, M. Ripple, C. Solomon, and A. Burke Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes Am J Cardiol 104 2009 571 577
26. E. Tadamura, M. Yamamuro, S. Kubo, S. Kanao, R. Hosokawa, T. Kimura, T. Kita, and K. Togashi Images in cardiovascular medicine: multimodality imaging of cardiac sarcoidosis before and after steroid therapy Circulation 113 2006 e771 e773
27. N. Tahara, A. Tahara, Y. Nitta, N. Kodama, M. Mizoguchi, H. Kaida, K. Baba, M. Ishibashi, N. Hayabuchi, J. Narula, and T. Imaizumi Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis J Am Coll Cardiol Img 3 2010 1219 1228
28. P.G. Masci, M. Marinelli, M. Piacenti, V. Lorenzoni, V. Positano, M. Lombardi, A. L'Abbate, and D. Neglia Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study Circ Cardiovasc Imaging 3 2010 482 490
29. H. Aso, K. Takeda, T. Ito, T. Shiraishi, K. Matsumura, and T. Nakagawa Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging Invest Radiol 33 1998 22 32
30. M.G. Friedrich, U. Sechtem, J. Schulz-Menger, and et al. for the International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper J Am Coll Cardiol 53 2009 1475 1487
31. A. Uemura, S. Morimoto, S. Hiramitsu, Y. Kato, T. Ito, and H. Hishida Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies Am Heart J 138 1999 299 302
32. K. Ishibashi, M. Takeda, and Y. Yamahara Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis Intern Med 52 2013 1341 1345
33. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543